EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Knockdown of circADAM9 inhibits cell progression and glycolysis by targeting the miR ‐1236‐3p/ FGF7 axis in breast cancer

Bo Huang, Yichao Zhang, Peng Sun, Jianshan Lin iD, Cunchuan Wang

Thoracic Cancer · 2023

DOI: 10.1111/1759-7714.15025 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Thoracic Cancer, 2023. Verfasst von Bo Huang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, People's Hospital of Shenzhen Baoan District, Shenzhen, China. Hauptthemen laut MEDLINE: Breast Neoplasms, MicroRNAs. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Circular RNAs (circRNAs) are closely associated with the development of breast cancer (BC). In this study, we aimed to clarify how differentially expressed circRNAs affect the development of BC.

Methods

Quantitative real‐time polymerase chain reaction (qRT‐PCR) was used to detect the expression of circADAM9, miR‐1236‐3p and fibroblast growth factor 7 (FGF7). Colony formation, 5‐ethynyl‐2′‐deoxyuridine (EdU), wound healing, transwell, and flow cytometry were used to assess cell proliferation, migration, invasion, and apoptosis. Glucose consumption, lactic acid production and ATP levels were assessed using glycolysis metabolism analysis. Dual‐luciferase reporter assay and RNA immunoprecipitation (RIP) assay were carried out to verify the relationship between miR‐1236‐3p and circADAM9 or FGF7. The roles of cirADAM9 on tumor growth were analyzed using a xenograft tumor model. Ki‐67 and FGF7 expression was measured via immunohistochemistry (IHC) assay. Apoptosis‐related proteins and exosome markers were detected by western blot.

Results

CircADAM9 was highly expressed in BC cells, and circADAM9 silencing inhibited BC cell proliferation, migration, invasion, and glycolysis, and promoted cell apoptosis. Furthermore, miR‐1236‐3p inhibition could overturn circADAM9 knockdown‐mediated BC inhibition. Moreover, the negative influences of miR‐1236‐3p overexpression on BC progression were restrained via FGF7 overexpression. CircADAM9 silence also inhibited BC tumor growth in vivo.

Conclusion

CircADAM9 promoted BC development partly by the miR‐1236‐3p/FGF7 axis, highlighting a potential prognostic biomarker and therapeutic target for BC patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsMicroRNAsHumansAnimalsFemaleFibroblast Growth Factor 7RNA, CircularCell ProliferationDisease Models, AnimalGlycolysisCell Line, Tumor

Stichwörter der Autor:innen

FGF7People’s Hospital of Shenzhen Baoan Districtbreast cancercircADAM9miR-1236-3p

Substanzen

Fibroblast Growth Factor 7RNA, CircularMicroRNAsFGF7 protein, humanMIRN1236 microRNA, human

Autor:innen und Institutionen

  • Department of General Surgery, People's Hospital of Shenzhen Baoan District, Shenzhen, China.
  • Department of Thyroid and Breast Surgery, People's Hospital of Shenzhen Baoan District, Shenzhen, China.

ORCID-Profile: Jianshan Lin

Zitieren

APA

Huang, B., Zhang, Y., Sun, P., Lin, J., & Wang, C. (2023). Knockdown of circADAM9 inhibits cell progression and glycolysis by targeting the miR ‐1236‐3p/ FGF7 axis in breast cancer. Thoracic Cancer. https://doi.org/10.1111/1759-7714.15025

Vancouver

Huang B, Zhang Y, Sun P, Lin J, Wang C. Knockdown of circADAM9 inhibits cell progression and glycolysis by targeting the miR ‐1236‐3p/ FGF7 axis in breast cancer. Thoracic Cancer. 2023. doi:10.1111/1759-7714.15025

BibTeX
@article{Huang2023,
  author = {Huang, Bo and Zhang, Yichao and Sun, Peng and Lin, Jianshan and Wang, Cunchuan},
  title = {Knockdown of circADAM9 inhibits cell progression and glycolysis by targeting the miR ‐1236‐3p/ FGF7 axis in breast cancer},
  journal = {Thoracic Cancer},
  year = {2023},
  doi = {10.1111/1759-7714.15025}
}
Kostenlos starten →